Skip to main content
. 2024 Jan 27;73(2):23. doi: 10.1007/s00262-023-03608-y

Fig. 6.

Fig. 6

Relative abundance of Butyricimonas is associated with differences in survival rate. A ROC according to patient with esophageal cancer calculated by cross-validated random forest models. B Kaplan–Meier estimates for survival probability based on the abundance levels of Butyricimonas in patient with esophageal cancer after surgery. C Kaplan–Meier estimates for survival probability based on the abundance levels of Butyricimonas in the postoperative recurrence group